Notably, male BRCA2 PVs carriers are significantly more likely to develop cancer, particularly BC, and are at increased risk of developing second breast and non-breast tumors, compared to male BRCA1 PVs carriers [72]. The gene discussed is BRCA2; the disease is cancer.